281 related articles for article (PubMed ID: 20237413)
1. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.
Cherfils-Vicini J; Platonova S; Gillard M; Laurans L; Validire P; Caliandro R; Magdeleinat P; Mami-Chouaib F; Dieu-Nosjean MC; Fridman WH; Damotte D; Sautès-Fridman C; Cremer I
J Clin Invest; 2010 Apr; 120(4):1285-97. PubMed ID: 20237413
[TBL] [Abstract][Full Text] [Related]
2. [Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance].
Cherfils-Vicini J; Damotte D; Fridman WH; Sautès-Fridman C; Cremer I
Med Sci (Paris); 2010 Apr; 26(4):435-7. PubMed ID: 20412752
[No Abstract] [Full Text] [Related]
3. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
Hamm S; Rath S; Michel S; Baumgartner R
J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
[TBL] [Abstract][Full Text] [Related]
4. TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer.
Grimmig T; Matthes N; Hoeland K; Tripathi S; Chandraker A; Grimm M; Moench R; Moll EM; Friess H; Tsaur I; Blaheta RA; Germer CT; Waaga-Gasser AM; Gasser M
Int J Oncol; 2015 Sep; 47(3):857-66. PubMed ID: 26134824
[TBL] [Abstract][Full Text] [Related]
5. RNA recognition via TLR7 and TLR8.
Hornung V; Barchet W; Schlee M; Hartmann G
Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
[TBL] [Abstract][Full Text] [Related]
6. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
[TBL] [Abstract][Full Text] [Related]
7. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.
Smits EL; Ponsaerts P; Berneman ZN; Van Tendeloo VF
Oncologist; 2008 Aug; 13(8):859-75. PubMed ID: 18701762
[TBL] [Abstract][Full Text] [Related]
8. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
9. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
[TBL] [Abstract][Full Text] [Related]
10. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
11. TLR8 activates HIV from latently infected cells of myeloid-monocytic origin directly via the MAPK pathway and from latently infected CD4+ T cells indirectly via TNF-α.
Schlaepfer E; Speck RF
J Immunol; 2011 Apr; 186(7):4314-24. PubMed ID: 21357269
[TBL] [Abstract][Full Text] [Related]
12. The covalent modification and regulation of TLR8 in HEK-293 cells stimulated with imidazoquinoline agonists.
Rajagopal R; Waller AS; Mendoza JD; Wightman PD
Biochem J; 2008 Jan; 409(1):275-87. PubMed ID: 17868034
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of toll-like receptors 7 and 8 in brain and lung tissues of death cases caused by EV71 infection].
Li B; Ma HM; Wang XX; Li YQ; Liu HB; Hong LZ; Li X; Zheng WH; Ou WL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1051-5. PubMed ID: 26483222
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: evidence of anergy.
Kumar MM; Adurthi S; Ramachandran S; Mukherjee G; Joy O; Krishnamurthy H; Krishna S; Bafna UD; Uma DK; Jayshree RS
Int J Gynecol Cancer; 2013 Jan; 23(1):184-92. PubMed ID: 23221735
[TBL] [Abstract][Full Text] [Related]
17. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
18. Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs.
Hung YF; Chen CY; Shih YC; Liu HY; Huang CM; Hsueh YP
J Cell Biol; 2018 Aug; 217(8):2727-2742. PubMed ID: 29777026
[TBL] [Abstract][Full Text] [Related]
19. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
20. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
